Caption Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Caption Management's BBIO Position: Q3 2026 in Review
Caption Management opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 21,800 shares worth $1.43M. The stake represents 0.01% of the portfolio and ranks #1132 among its holdings. This is a return to the name: Caption Management previously reported a position in BBIO as recently as Q1 2026.
Caption Management first reported a position in BBIO in Q4 2021 and has held it in 10 quarters since. The position peaked at $10.3M in Q2 2024. 470 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Caption Management held 21,800 shares of BridgeBio Pharma worth $1.43M as of Q3 2026.
- BridgeBio Pharma was a new Caption Management position in Q3 2026.
- BridgeBio Pharma made up 0.01% of Caption Management's portfolio in Q3 2026, its #1132 holding.
- Caption Management first reported a position in BridgeBio Pharma in Q4 2021 and has held it in 10 quarters since.
- Caption Management's BridgeBio Pharma position peaked at $10.3M in Q2 2024.
- 470 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.